AMS:DSFIR - CH1216478797 - Common Stock
The current stock price of DSFIR.AS is 81.56 EUR. In the past month the price decreased by -0.39%. In the past year, price decreased by -31.41%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
GIN.DE | GIVAUDAN-REG | 27.53 | 33.86B | ||
SIKA.DE | SIKA AG-REG | 23.93 | 31.22B | ||
6D81.DE | DUPONT DE NEMOURS INC | 16.91 | 27.11B | ||
BRG.OL | BORREGAARD ASA | 23.31 | 20.70B | ||
ELK.OL | ELKEM ASA | N/A | 15.82B | ||
1IFF.MI | INTL FLAVORS & FRAGRANCES | 15.42 | 14.78B | ||
SY1.DE | SYMRISE AG | 23.08 | 11.71B | ||
1COV.DE | COVESTRO AG | N/A | 11.33B | ||
AKZA.AS | AKZO NOBEL N.V. | 15.7 | 10.13B | ||
AMC.DE | ALBEMARLE CORP | N/A | 8.02B | ||
SYENS.BR | SYENSQO SA | 20.28 | 7.86B | ||
EVK.DE | EVONIK INDUSTRIES AG | 9.65 | 7.51B |
DSM-Firmenich AG is an innovator in nutrition, health, and beauty. The firm operates in four complementary businesses Perfumery & Beauty, which offer perfumery, fragrance ingredients and personal and care aroma; Taste, Texture & Health, which produces nutritional products with natural flavours and ingredients; Health, Nutrition & Care division offers customized products that contain vitamins, nutritional lipids, digestive enzymes, probiotics and cannabinoids (CBD); Animal Nutrition & Health business offers customer tailored products, solutions and services for animal farming that contain vitamins, animal proteins, carotenoids and premixes. The firm operates worldwide.
DSM-FIRMENICH AG
Wurmisweg 576, Kaiseraugst
Kaiseraugst AARGAU CH
Employees: 28214
The current stock price of DSFIR.AS is 81.56 EUR. The price decreased by -0.07% in the last trading session.
The exchange symbol of DSM-FIRMENICH AG is DSFIR and it is listed on the Euronext Amsterdam exchange.
DSFIR.AS stock is listed on the Euronext Amsterdam exchange.
30 analysts have analysed DSFIR.AS and the average price target is 122.83 EUR. This implies a price increase of 50.6% is expected in the next year compared to the current price of 81.56. Check the DSM-FIRMENICH AG stock analysts ratings, price target forecast and up-and down grades for more detailed information.
DSM-FIRMENICH AG (DSFIR.AS) has a market capitalization of 21.67B EUR. This makes DSFIR.AS a Large Cap stock.
DSM-FIRMENICH AG (DSFIR.AS) currently has 28214 employees.
DSM-FIRMENICH AG (DSFIR.AS) has a support level at 81.34 and a resistance level at 82.57. Check the full technical report for a detailed analysis of DSFIR.AS support and resistance levels.
The Revenue of DSM-FIRMENICH AG (DSFIR.AS) is expected to grow by 0.77% in the next year. Check the estimates tab for more information on the DSFIR.AS EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
DSM-FIRMENICH AG (DSFIR.AS) has a dividend yield of 2.97%. The yearly dividend amount is currently 0. Check the full fundamental report for a detailed analysis of DSFIR.AS dividend history, reliability and sustainability.
DSM-FIRMENICH AG (DSFIR.AS) will report earnings on 2025-10-30.
The PE ratio for DSM-FIRMENICH AG (DSFIR.AS) is 86.77. This is based on the reported non-GAAP earnings per share of 0.94 and the current share price of 81.56 EUR. Check the full fundamental report for a full analysis of the valuation metrics for DSFIR.AS.
ChartMill assigns a fundamental rating of 3 / 10 to DSFIR.AS. The financial health of DSFIR.AS is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months DSFIR.AS reported a non-GAAP Earnings per Share(EPS) of 0.94. The EPS decreased by -89.7% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 1.95% | ||
ROA | 0.77% | ||
ROE | 1.17% | ||
Debt/Equity | 0.24 |
30 analysts have analysed DSFIR.AS and the average price target is 122.83 EUR. This implies a price increase of 50.6% is expected in the next year compared to the current price of 81.56.
For the next year, analysts expect an EPS growth of 24.72% and a revenue growth 0.77% for DSFIR.AS